Soothing Scents Blog

October 2019 -In a trial conducted by Kaiser Permanente Fontana Medical Center results revealed 67% of patients did not require additional antiemetics after administering QueaseEASE in the PACU setting and 100% of the trial participants stated they found QueaseEASE to be beneficial. TEAM LEADERS Sarah Todd, BSN, RNLisa Haas, BSN, RN DATA ANALYSIS Dean McCann, Data Consultant, Perioperative Services BACKGROUND

In a trial by Kaiser Permanente Fontana Medical Center results revealed 67% of patients did not require additional antiemetics after administering QueaseEASE in the PACU setting and 100% of the trial participants stated they found QueaseEASE to be beneficial. DATE: October 2019 READ THE FULL STUDY BELOW: BACKGROUND Quality improvement projects have shown that aromatherapy can be used as an

A small trial conducted in the PACU found that 15 out of 52 of the patients did not require any additional antiemetics after receiving QueaseEASE®, resulting in a cost savings of $750. AUTHOR(S): Cathy Nolte Slupik BSN RN CCRN Mission Hospital of Providence St Joseph Health, Mission Viejo, California. Team Members: Margie Whittaker MSN RN, Debbie Busby-Edebiri BSN RN CNOR

An evaluative trial done by the Sutter Health Alta Bates Summit Medical Center, revealed that QueaseEASE® helped to relieve PONV in 70% of PACU patients.  AUTHOR(S): Study lead by Patricia Crosby, RN, BSN, MA, CCRN, CPAN, Staff Nurse IV, Luvimin Rzepiela, RN, BSN, CAPA, Staff Nurse III DATE: March 2016 READ THE FULL STUDY BELOW: BACKGROUND INFORMATION Postoperative nausea and